Found 4 matching trials
Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents
PHASE3This study is a multi-center, randomized, double-blind Phase III clinical t...
Location
Multiple Locations
Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months
PHASE3This study assesses immunogenicity and safety of NBP607-QIV to Agrippal whi...
Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months
PHASE3This study is a multi-center, randomized, double-blind Phase III Clinical t...
Location
Korea University ANSAN hospital
Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly Subjects
PHASE3All participants received a single dose of their assigned vaccine on Day 0....
Location
Multiple Locations